Phase I trial of veliparib, (ABT-888), a poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with doxorubicin and cyclophosphamide in breast cancer and other solid tumors.
A. R. Tan
No relevant relationships to disclose
D. Toppmeyer
No relevant relationships to disclose
M. N. Stein
No relevant relationships to disclose
R. A. Moss
No relevant relationships to disclose
M. Gounder
No relevant relationships to disclose
D. C. Lindquist
No relevant relationships to disclose
J. J. Ji
No relevant relationships to disclose
A. P. Chen
No relevant relationships to disclose
M. J. Egorin
No relevant relationships to disclose
B. Kiesel
No relevant relationships to disclose
J. H. Beumer
No relevant relationships to disclose
R. S. DiPaola
No relevant relationships to disclose